Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
L-Glutamine and Spirulina are closely matched across evidence, studies, and safety.
Verdict
Likely helps
3 of 3 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
11 of 12 studies with measurable effects showed benefit.
Top outcomes
5-10g
Post-workout, Before bed, Or split throughout day
L-Glutamine powder
3-10g daily
With food to mask taste, Morning for energy, Before meals for appetite effects
Powder or tablets
2-4 weeks
2-4 weeks
1-2 weeks
8-12 weeks
4-8 weeks
2-4 weeks
Immediate
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
The New England journal of medicine (2018) · Rct · n=230
A total of 230 patients (age range, 5 to 58 years; 53.9% female) were randomly assigned, in a 2:1 ratio, to receive l-glutamine (152 patients) or placebo (78 patients).
What Is the Role of Nutritional Supplements in Support of Total Hip Replacement and Total Knee Replacement Surgeries? A Systematic Review
Nutrients (2018) · Systematic review
Amino acid supplementation is reported to reduce muscle atrophy and accelerate return of functional mobility.
Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies
Blood reviews (2025) · Systematic review · n=97
A pivotal phase III study of l-glutamine showed that patients treated with l-glutamine had a 25 % reduction in pain crises and 33 % fewer hospital days compared to placebo. l-glutamine was generally well tolerated with minimal side effects.
Systematic Review of the Effects of Plant-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities Such as Obesity, Metabolic Syndrome, and Type 2 Diabetes
Nutrients (2025) · Systematic review
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become one of the most prevalent liver diseases, affecting up to 40% of adults and strongly associated with obesity and metabolic dysfunction.
The Role of Chlorella and Spirulina as Adjuvants of Cardiovascular Risk Factor Control: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Nutrients (2025) · Meta analysis · n=12
On the other hand, Spirulina intake led to a significant reduction in diastolic BP (-0.42, 95% CI: -0.81 to -0.02, p = 0.04) but did not significantly affect lipemia indexes, despite a trend toward a reduction in total cholesterol (-0.17, 95% CI: -0.39 to 0.06, p = 0.15).
Edible Algae Reduce Blood Pressure in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Journal of human nutrition and dietetics : the official journal of the British Dietetic Association (2025) · Meta analysis · n=1583
Edible algae intake significantly reduced systolic BP (SBP: -2.05 mmHg; 95% CI: -3.80, -0.31; p = 0.022) and diastolic BP (DBP: -1.87 mmHg; 95% CI: -3.10, -0.64; p = 0.001).
Based on RCT showing reduced URTI incidence in combat athletes (n=21) and enhanced IgA levels. Limited sample size and specific population studied. Effect may be primarily in high-stress/training conditions.
Based on multiple meta-analyses showing dose-dependent effects. LDL reduction of ~33mg/dL and triglycerides ~39mg/dL reported. Effects appear to plateau above 8-10g daily.
AI-estimated from published studies. Interpret as directional guidance.
Both L-Glutamine and Spirulina are closely matched — the best choice depends on your specific health goals.
For reduce inflammation, L-Glutamine has a higher relevance score (85 vs 65).
No known interactions between L-Glutamine and Spirulina have been documented in our database. However, always consult a healthcare provider before combining supplements.